The Grifols family won’t support a new bid by a third-party to take its namesake drug-maker private amid indications that ...

Canadian fund Brookfield is planning to drop its plan to take over Spain's Grifols, two sources close to the matter said on ...

Shares in Grifols were falling on Wednesday morning after Bloomberg reported Canadian fund Brookfield is considering dropping ...

Brookfield Asset Management Ltd. is preparing to walk away from a plan to acquire Grifols SA over disagreements on valuation for the Spanish drug maker, according to people familiar with the matter.

With Spanish plasma specialist Grifols turning down a potential multi-billion-dollar takeover bid, it’s likely back to the ...

Grifols SA’s board of directors said it won’t recommend that shareholders accept Brookfield Asset Management’s indicative ...

Grifols (GRFS) stock gains as banks aim to finalize an €11B debt package for Brookfield's (BAM) plan to take the healthcare ...

Grifols is anticipating a period of strong growth on the back of its recently FDA-approved intravenous immunoglobulin product ...

Nov 18 (Reuters) - Canadian fund Brookfield (BN.TO), opens new tab plans to offer about 7 billion euros ($7.4 billion) for ...

(Bloomberg) -- Grifols SA’s board recommended that shareholders reject Brookfield Asset Management’s indicative offer, which values the Spanish drugmaker at €6.45 billion ($6.8 billion).

Brookfield Asset Management Ltd. is considering a €6.45 billion (US$6.9 billion) bid for Grifols SA, with the drug maker’s ...

(Bloomberg) -- Grifols SA’s board recommended that shareholders reject Brookfield Asset Management’s indicative offer, which values the Spanish drugmaker at €6.45 billion ($6.8 billion).Most ...